BIOMAT Database Logo BIOMAT Database Logo

[The immunogenic properties of the liposomal form of Pseudomonas aeruginosa anatoxin in burned and irradiated mice]. 1993

V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D011833 Radiation Injuries, Experimental Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals. Experimental Radiation Injuries,Injuries, Experimental Radiation,Experimental Radiation Injury,Radiation Injury, Experimental
D002056 Burns Injuries to tissues caused by contact with heat, steam, chemicals (BURNS, CHEMICAL), electricity (BURNS, ELECTRIC), or the like. Burn
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D005720 Gamma Rays Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source. Gamma Wave,Gamma Radiation,Nuclear X-Rays,Radiation, Gamma,X-Rays, Nuclear,Gamma Radiations,Gamma Ray,Gamma Waves,Nuclear X Rays,Nuclear X-Ray,Ray, Gamma,Wave, Gamma,Waves, Gamma,X Rays, Nuclear,X-Ray, Nuclear
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
[The protective properties of Pseudomonas aeruginosa anatoxin].
January 1985, Mikrobiologicheskii zhurnal,
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
[Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum].
June 1986, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide.
June 1990, Infection and immunity,
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
[Immunogenic properties of the liposomal form of the rabies vaccine].
January 1988, Voprosy virusologii,
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
Immunogenic properties of liposomal model membranes in mice.
December 1977, Journal of immunology (Baltimore, Md. : 1950),
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
Immunogenic properties of slime produced by Pseudomonas aeruginosa.
January 1979, Archivum immunologiae et therapiae experimentalis,
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
[Immunogenic properties and specificity of pseudomonas aeruginosa polyvalent vaccine].
January 1981, Medycyna doswiadczalna i mikrobiologia,
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
[Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
July 1980, Polski tygodnik lekarski (Warsaw, Poland : 1960),
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
The prevention of Pseudomonas aeruginosa infections in irradiated mice and rats.
November 1957, Radiation research,
V V Minukhin, and N S Brodinova, and A Ia Tsyganenko, and V L Tkachenko, and N N Ivanova, and V N Vasil'chenko
PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice.
September 2001, Infection and immunity,
Copied contents to your clipboard!